Oxford Biomedica PLC Director/PDMR Shareholding (8619P)
September 05 2017 - 5:39AM
UK Regulatory
TIDMOXB
RNS Number : 8619P
Oxford Biomedica PLC
05 September 2017
Notification of Transactions of Directors/Persons Discharging
Managerial Responsibility and Connected Persons
1 Issuer Oxford BioMedica PLC
------ ------------------------ -----------------------------------
2 Reason for notification Notification relates to DTR
3.1.2R
------ ------------------------ -----------------------------------
3 Name of PDMR Martin Diggle
------ ------------------------ -----------------------------------
4 Connected person Notification relates to following
connected persons:
Vulpes Testudo Fund
------ ------------------------ -----------------------------------
5 Notification Notification in respect of
in respect of holdings of persons in 4 above
------ ------------------------ -----------------------------------
6 Description Oxford BioMedica PLC ordinary
of shares shares of 1p each
------ ------------------------ -----------------------------------
7 Name of registered Vulpes Life Sciences Fund
shareholders - 549,932,000 shares
and number of Vulpes Testudo Fund - 30,956,834
shares shares
------ ------------------------ -----------------------------------
8 Nature of transaction Acquisition and Disposal
------ ------------------------ -----------------------------------
9 Number of shares Vulpes Testudo Fund - 320,000
acquired shares
------ ------------------------ -----------------------------------
10 Percentage of Vulpes Testudo Fund- 0.01%
issued class
acquired
------ ------------------------ -----------------------------------
11 Shares disposed Vulpes Testudo Fund - 300,000
------ ------------------------ -----------------------------------
12 Percentage of Vulpes Testudo Fund - 0.01%
issued class
disposed
------ ------------------------ -----------------------------------
13/14 Price per share Vulpes Testudo Fund
of transactions, Sold 300,000 shares @ GBP0.097,
and date 01 Sep 2017
Bought 320,000 shares @ GBP0.094,
01 Sep 2017
------ ------------------------ -----------------------------------
15 Total holding Vulpes Life Sciences Fund
following notification - 549,932,000 shares
and total percentage 17.7%
holding following Vulpes Testudo Fund - 30,976,434
notification shares
1.0%
------ ------------------------ -----------------------------------
16 Date issuer 05 Sep 2017
informed
------ ------------------------ -----------------------------------
23 Any additional None
information
------ ------------------------ -----------------------------------
24 Contact name S. Paynter, Chief Financial
and telephone Officer
number Oxford BioMedica
+44 (0)1865 783000
------ ------------------------ -----------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBGGDCRXGBGRU
(END) Dow Jones Newswires
September 05, 2017 06:39 ET (10:39 GMT)
Oxford Biomedica (LSE:OXB)
Historical Stock Chart
From Apr 2024 to May 2024
Oxford Biomedica (LSE:OXB)
Historical Stock Chart
From May 2023 to May 2024
